Peer-reviewed publications
Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis – Pensée Wu, Caroline van den Berg, Zarko Alfirevic, Shaughn O’Brien, Maria Röthlisberger, Philip Newton Baker, Louise C. Kenny, Karolina Kublickiene and Johannes J. Duvekot. Int. J. Mol. Sci. 2015, 16(9), 23035-23056. https://doi.org/10.3390/ijms160923035
Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments – Neily Zakiyah, Maarten J. Postma, Philip N. Baker, Antoinette D. I. van Asselt, On behalf of the IMPROvED Consortium. PharmacoEconomics 2015:291. Published online: 06 Jun 2015.
doi: 10.1007/s40273-015-0291-x
Preeclampsia risk stratification early in pregnancy: Levering a promising metabolomics discovery in a LC–MS based clinical assay – Bond, Liz et al. In: Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, Volume 5, Issue 1, 82. January 2015. https://doi.org/10.1016/j.preghy.2014.10.164
A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED) – Kate Navaratnam, Zarko Alfirevic, Philip N Baker, Christian Gluud, Berthold Grüttner, Karolina Kublickiene, Gerda Zeeman and Louise C Kenny. BMC Pregnancy and Childbirth 2013, 13:226. https://doi.org/10.1186/1471-2393-13-226
Other publications
Press Release May 2018:
The EU-funded project IMPROvED established a unique collaborative
framework between innovative SMEs and a network of European clinicians
and Researchers to enable the development of a clinically robust predictive blood test for pre-eclampsia in first time pregnant women.
Conference presentations
Preeclampsia risk stratification early in pregnancy: First results of a new LC-MS based multiplex metabolite assay – Liz Bond, Grégoire Thomas, Caroline Nolan, Peter Christensen,Phil
Baker, Louise Kenny, Robin Tuytten. Presented at the MSACL 2015 EU,
Salzburg, Austria: Sept 8-11.
Poster presentations
Preeclampsia risk stratification early in pregnancy: First results of a new LC-MS based multiplex metabolite assay – Liz Bond, Grégoire Thomas, Caroline Nolan, Peter Christensen,Phil Baker, Louise Kenny, Robin Tuytten. Presented at the ISSHP 2015, Budapest, Hungary.
Quality within the EU-FP7 IMPROvED Biobank – EM Guiney-Snapes, PN Baker, Z Alfirevic, M Kublickas, JJ Duvekot, B Grüttner, C Gluud, S Marthinsson, K Verleysen, C Garvey, J Müller and LC Kenny. Presented at the ESBB Biobanking conference in Leipzig, Germany, 21 – 24 October, 2014.
Preeclampsia risk stratification early in pregnancy: leveraging a promising metabolomics discovery into a LC-MS based clinical assay – Liz Bond, Caroline Nolan, Katy Hyland, Charline Lenaerts, Philip N. Baker, Louise C. Kenny, Robin Tuytten. Presented at the ISSHP 2014, New Orleans, USA.
Economic Assessment of Pre-eclampsia: Screening, Diagnosis, Treatment Options, and Long Term Outcomes – Zakiyah N, van Asselt ADI, Baker PN, Postma MJ on behalf of the IMPROvED consortium. Presented at the ISPOR 17th Annual Congress 2014, Amsterdam, PIH14.
Preeclampsia risk stratification early in pregnancy: Conversion of a promising metabolomics discovery into a LC-MS based clinical assay – Liz Bond, CharlineLenaerts, Christopher Benton, Phil Baker, Louise Kenny, Robin Tuytten.
Presented at the MSACL 2014 EU, Salzburg, Austria: Sept 2-5.
IMPROvED: A multicentre clinical study to develop a predictive blood test for pre-eclampsia – Boel Niklasson, Karolina Kublickiene, Marius Kublickas, Caroline van
den Berg, Johannes Duvekot, Zarko Alfirevic, Shaughn O’Brien, Philip
Baker, Christoph Berg, Berthold Grüttner, Louise Kenny. Presented at the
39th Nordic Congress of Obstetrics and Gynecology, June 2014 Stockholm.
